AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionMAI Capital Management
Latest Disclosed Ownership577,833 shares
Latest Disclosed Value $ 125,672,999
MAI Capital Management ownership in 4AB / AbbVie Inc.

On May 15, 2026 - MAI Capital Management filed a 13F-HR form disclosing ownership of 577,833 shares of AbbVie Inc. (BG:4AB) valued at $125,672,999 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 576,067 shares of AbbVie Inc.. This represents a change in shares of 0.31% during the quarter.

MAI Capital Management has a history of taking positions in derivatives of the underlying security (4AB) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

BG:4AB / AbbVie Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ABBVIE COM 00287Y109 577,833 1,766 0.31 125,673 -4.52 0.7093
2026-02-13 2025-12-31 13F ABBVIE COM 00287Y109 576,067 29,783 5.45 131,625 4.06 0.7570
2025-11-10 2025-09-30 13F ABBVIE COM 00287Y109 546,284 6,850 1.27 126,487 26.32 0.7878
2025-08-12 2025-06-30 13F ABBVIE COM 00287Y109 539,434 19,996 3.85 100,130 -8.00 0.6919
2025-05-15 2025-03-31 13F ABBVIE COM 00287Y109 519,438 19,745 3.95 108,833 22.57 0.8204
2025-02-14 2024-12-31 13F ABBVIE COM 00287Y109 499,693 141,380 39.46 88,795 25.49 0.6579
2024-11-07 2024-09-30 13F Abbvie CS 00287Y109 358,313 -14,772 -3.96 70,760 10.58 0.6737
2024-08-12 2024-06-30 13F Abbvie CS 00287Y109 373,085 2,235 0.60 63,992 -5.24 0.6269
2024-05-08 2024-03-31 13F Abbvie CS 00287Y109 370,850 24,229 6.99 67,532 25.72 0.6997
2024-02-09 2023-12-31 13F Abbvie CS 00287Y109 346,621 2,218 0.64 53,716 4.63 0.7061
2023-11-14 2023-09-30 13F Abbvie CS 00287Y109 344,403 11,807 3.55 51,337 14.56 0.7634
2023-08-02 2023-06-30 13F Abbvie CS 00287Y109 332,596 -12,686 -3.67 44,811 -18.57 0.6593
2023-05-10 2023-03-31 13F Abbvie CS 00287Y109 345,282 -1,357 -0.39 55,028 -1.77 0.8668
2023-02-09 2022-12-31 13F Abbvie CS 00287Y109 346,639 12,629 3.78 56,020 24.97 0.9411
2022-11-15 2022-09-30 13F Abbvie CS 00287Y109 334,010 33,749 11.24 44,827 -2.52 0.8420
2022-07-19 2022-06-30 13F Abbvie CS 00287Y109 300,261 1,939 0.65 45,988 -4.91 0.8782
2022-05-10 2022-03-31 13F Abbvie CS 00287Y109 298,322 4,289 1.46 48,361 21.47 0.8127
2022-02-11 2021-12-31 13F AbbVie CS 00287Y109 294,033 64,837 28.29 39,812 61.03 0.6414
2021-11-12 2021-09-30 13F AbbVie CS 00287Y109 229,196 5,196 2.32 24,723 -2.01 0.4760
2021-07-19 2021-06-30 13F AbbVie CS 00287Y109 224,000 -20,535 -8.40 25,231 -4.66 0.5008
2021-05-10 2021-03-31 13F AbbVie CS 00287Y109 244,535 -55,424 -18.48 26,464 -17.66 0.5915
2021-02-16 2020-12-31 13F AbbVie CS 00287Y109 299,959 13,479 4.71 32,141 28.09 0.8037
2020-10-26 2020-09-30 13F AbbVie CS 00287Y109 286,480 -61,185 -17.60 25,093 -26.49 0.7265
2020-07-27 2020-06-30 13F AbbVie CS 00287Y109 347,665 261,473 303.36 34,134 419.78 1.0716
2020-04-16 2020-03-31 13F AbbVie CS 00287Y109 86,192 -5,601 -6.10 6,567 -19.20 0.2680
2020-02-03 2019-12-31 13F AbbVie CS 00287Y109 91,793 30,976 50.93 8,127 76.48 0.2634
2019-10-29 2019-09-30 13F AbbVie CS 00287Y109 60,817 524 0.87 4,605 5.02 0.2052
2019-08-15 2019-06-30 13F AbbVie CS 00287Y109 60,293 -93 -0.15 4,385 -9.90 0.1981
2019-04-29 2019-03-31 13F AbbVie CS 00287Y109 60,386 330 0.55 4,867 -12.10 0.2492
2019-01-30 2018-12-31 13F AbbVie CS 00287Y109 60,056 8,561 16.62 5,537 13.70 0.3227
2018-10-12 2018-09-30 13F AbbVie CS 00287Y109 51,495 -526 -1.01 4,870 1.04 0.2488
2018-08-16 2018-06-30 13F AbbVie CS 00287Y109 52,021 2,533 5.12 4,820 2.90 0.2600
2018-04-17 2018-03-31 13F AbbVie CS 00287Y109 49,488 4,573 10.18 4,684 7.83 0.2659
2018-01-30 2017-12-31 13F AbbVie CS 00287Y109 44,915 7,048 18.61 4,344 29.09 0.2468
2017-10-12 2017-09-30 13F AbbVie CS 00287Y109 37,867 2 0.01 3,365 22.54 0.2043
2017-08-07 2017-06-30 13F AbbVie CS 00287Y109 37,865 114 0.30 2,746 11.63 0.1769
2017-05-11 2017-03-31 13F AbbVie CS 00287Y109 37,751 -1,210 -3.11 2,460 0.82 0.1655
2017-01-31 2016-12-31 13F AbbVie CS 00287Y109 38,961 1,273 3.38 2,440 2.65 0.1774
2016-10-18 2016-09-30 13F AbbVie CS 00287Y109 37,688 58 0.15 2,377 2.02 0.1793
2016-07-14 2016-06-30 13F AbbVie CS 00287Y109 37,630 -1,594 -4.06 2,330 4.02 0.1796
2016-04-08 2016-03-31 13F AbbVie CS 00287Y109 39,224 2,000 5.37 2,240 1.59 0.1713
2016-01-27 2015-12-31 13F AbbVie CS 00287Y109 37,224 -1,931 -4.93 2,205 3.52 0.1681
2015-10-28 2015-09-30 13F AbbVie CS 00287Y109 39,155 146 0.37 2,130 -18.73 0.1611
2015-07-09 2015-06-30 13F AbbVie CS 00287Y109 39,009 -384 -0.97 2,621 13.66 0.1727
2015-04-30 2015-03-31 13F AbbVie CS 00287Y109 39,393 1,802 4.79 2,306 -6.26 0.1545
2015-01-20 2014-12-31 13F AbbVie CS 00287Y109 37,591 -663 -1.73 2,460 11.31 0.1725
2014-10-16 2014-09-30 13F/A-1 AbbVie CS 00287Y109 38,254 -3,318 -7.98 2,210 -5.80 0.2129
2014-10-16 2014-09-30 13F AbbVie COM 00287Y109 41,572 2,346
2014-07-28 2014-06-30 13F AbbVie COM 00287Y109 41,572 -16,781 -28.76 2,346 -21.77 0.2254
2014-04-28 2014-03-31 13F AbbVie COM 00287Y109 58,353 -193,063 -76.79 2,999 -77.41 0.3019
2014-02-06 2013-12-31 13F AbbVie COM 00287Y109 251,416 -15,413 -5.78 13,277 11.24 1.4076
2013-10-28 2013-09-30 13F Abbvie COM 00287Y109 266,829 -1,830 -0.68 11,935 7.46 1.5509
2013-08-01 2013-06-30 13F Abbvie COM 00287Y109 268,659 268,659 11,106 1.4476
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2019-04-29 2019-03-31 13F AbbVie CS Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-01-30 2018-12-31 13F AbbVie CS Call 2,000 0.00 184 -2.65 n/a n/a n/a
2018-10-12 2018-09-30 13F AbbVie CS Call 2,000 0.00 189 2.16 n/a n/a n/a
2018-08-16 2018-06-30 13F AbbVie CS Call 2,000 0.00 185 -2.12 n/a n/a n/a
2018-04-17 2018-03-31 13F AbbVie CS Call 2,000 189 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-07-19 2021-06-30 13F AbbVie CS Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-10 2021-03-31 13F AbbVie CS Put 300 32 n/a n/a n/a
2020-02-03 2019-12-31 13F AbbVie CS Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-10-29 2019-09-30 13F AbbVie CS Put 8,100 0.00 613 4.07 n/a n/a n/a
2019-08-15 2019-06-30 13F AbbVie CS Put 8,100 0.00 589 -9.80 n/a n/a n/a
2019-04-29 2019-03-31 13F AbbVie CS Put 8,100 653 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.